Need pharma insights? Register for Evaluate Discovery

Newsletter Sign-Up

Product Login

Resources

Resource Centre

Looking for the latest from the Evaluate team? Below you’ll find our latest blogs, reports, webinars and more. Whether you’re looking for detailed analysis of the state of the biopharma market, or a quick primer on a particular topic, you’re in the right place.

On Demand Webinar

Inside #JPM2026:

The Stories Behind the Summit

Watch Now
Content Type
Topic

Most Recent

2025-review-capitals-better
2025 Review: Capital’s Better
Report/eBook
March 20, 2026
Biopharma capital returned in 2025. But not for everyone. After a significant dry spell, capital began to flow back into biopharma in 2025. Though...
Three Things we Learned in our 2026 Orphan Drugs Webinar
Three Things we Learned in our 2026 Orphan Drugs Webinar
Blog
March 20, 2026
Orphan drugs are forecast to make up 21% of all prescription drug sales by 2032, according to Evaluate forecasts. So it’s hardly surprising that...
pressure-testing-ambition
Pressure testing ambition: Why Target Product Profiles Matter More Than Ever
Expert Interviews
March 18, 2026
In this series, Evaluate’s consultants discuss some of the key challenges that face the companies they work with across the pharma space. In...
od-26-fi
2026 Orphan Drugs Infographic:
Infographic
March 17, 2026
Orphan drug developers are navigating a more complex landscape. FDA decision making has proved unpredictable, and rare disease programs must...
Data Analysis and Business Intelligence Creating impactful visualizations that enhance decisionmaking and drive business success through informed insights and strategic planning
Unlock Strategic Insights for Pharma: Custom Competitive Intelligence and Landscape Monitoring
Webinar
March 12, 2026
Establish a consistent baseline: build an aligned, comprehensive view of competitor intelligence. Monitor in real-time: stay updated on clinical,...
orphan drugs for rare diseases
Orphan Drugs at a Crossroads: Bigger Numbers, Tougher Calls
Blog
March 12, 2026
Drugs for rare diseases have played an increasingly significant role in the biopharma market for years. I’ve been working on Evaluate’s annual...
Load More

Upcoming Webinars / View On Demand

Webinars

Looking to learn? Our webinar series brings together Evaluate’s experts with industry leaders to talk about the big issues of the day.

Learn more

News / Events / Press Releases

News & Events

Check out the latest news from Evaluate and find out where you can come to meet the team.

Learn more

Data-driven Reports / Infographics / Articles

Thought Leadership

Catch up with our insights on the big issues in pharma.

Learn more
Linkedin Instagram